Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048609091> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W3048609091 abstract "Abstract The expanding number of research studies utilizing the imiquimod‐induced psoriasiform dermatitis model attests to the usefulness of this procedure. Advantages of this model include rapid development of the skin response and cost‐effectiveness. A major limitation is that application of imiquimod cream over large areas of skin, as well as licking and ingestion of the cream, may lead to severe systemic inflammation, which can cause a general decline in health, splenomegaly, and death. In this protocol, Finn chambers are used to localize the imiquimod cream to a small area of the skin. This results in production of severe and reproducible psoriatic skin reactions with significantly less imiquimod, greatly reducing the possibility of untoward systemic effects. Moreover, having psoriasiform and control skin areas on the same mice decreases inter‐animal differences. The protocol can be readily adapted for other skin disease models involving topical application of test agents. This article also details functional measurements performed during assays, including skin thickness, blood perfusion, semiquantitative histopathological evaluation, determination of scaling score to monitor psoriatic symptoms, and collection of spleen and body weight data to identify systemic effects. © 2020 The Authors. Basic Protocol : Use of Finn chambers to induce psoriasiform skin reactions with imiquimod Support Protocol 1 : Measurement of double‐fold dorsal skin thickness Support Protocol 2 : Measurement of blood perfusion Support Protocol 3 : Determination of scaling score Support Protocol 4 : Semiquantitative histopathological scoring Support Protocol 5 : Assessment of systemic side effects in response to imiquimod application" @default.
- W3048609091 created "2020-08-18" @default.
- W3048609091 creator A5043477229 @default.
- W3048609091 creator A5043884861 @default.
- W3048609091 creator A5072519908 @default.
- W3048609091 creator A5081469281 @default.
- W3048609091 date "2020-08-13" @default.
- W3048609091 modified "2023-10-14" @default.
- W3048609091 title "A Localized Aldara (5% Imiquimod)–Induced Psoriasiform Dermatitis Model in Mice Using Finn Chambers" @default.
- W3048609091 cites W1939997832 @default.
- W3048609091 cites W2001020866 @default.
- W3048609091 cites W2077121920 @default.
- W3048609091 cites W2468627168 @default.
- W3048609091 cites W2518781036 @default.
- W3048609091 cites W2560835069 @default.
- W3048609091 cites W2563338971 @default.
- W3048609091 cites W2594840304 @default.
- W3048609091 cites W2789712611 @default.
- W3048609091 cites W2904383992 @default.
- W3048609091 cites W2918600981 @default.
- W3048609091 cites W3002958431 @default.
- W3048609091 doi "https://doi.org/10.1002/cpph.78" @default.
- W3048609091 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32790966" @default.
- W3048609091 hasPublicationYear "2020" @default.
- W3048609091 type Work @default.
- W3048609091 sameAs 3048609091 @default.
- W3048609091 citedByCount "7" @default.
- W3048609091 countsByYear W30486090912021 @default.
- W3048609091 countsByYear W30486090912022 @default.
- W3048609091 countsByYear W30486090912023 @default.
- W3048609091 crossrefType "journal-article" @default.
- W3048609091 hasAuthorship W3048609091A5043477229 @default.
- W3048609091 hasAuthorship W3048609091A5043884861 @default.
- W3048609091 hasAuthorship W3048609091A5072519908 @default.
- W3048609091 hasAuthorship W3048609091A5081469281 @default.
- W3048609091 hasBestOaLocation W30486090911 @default.
- W3048609091 hasConcept C16005928 @default.
- W3048609091 hasConcept C2779112978 @default.
- W3048609091 hasConcept C2779121184 @default.
- W3048609091 hasConcept C2780564577 @default.
- W3048609091 hasConcept C71924100 @default.
- W3048609091 hasConceptScore W3048609091C16005928 @default.
- W3048609091 hasConceptScore W3048609091C2779112978 @default.
- W3048609091 hasConceptScore W3048609091C2779121184 @default.
- W3048609091 hasConceptScore W3048609091C2780564577 @default.
- W3048609091 hasConceptScore W3048609091C71924100 @default.
- W3048609091 hasFunder F4320322192 @default.
- W3048609091 hasFunder F4320326762 @default.
- W3048609091 hasIssue "1" @default.
- W3048609091 hasLocation W30486090911 @default.
- W3048609091 hasLocation W30486090912 @default.
- W3048609091 hasOpenAccess W3048609091 @default.
- W3048609091 hasPrimaryLocation W30486090911 @default.
- W3048609091 hasRelatedWork W2013772581 @default.
- W3048609091 hasRelatedWork W2046703086 @default.
- W3048609091 hasRelatedWork W2054230488 @default.
- W3048609091 hasRelatedWork W2160110272 @default.
- W3048609091 hasRelatedWork W2164019769 @default.
- W3048609091 hasRelatedWork W2392085321 @default.
- W3048609091 hasRelatedWork W3021885120 @default.
- W3048609091 hasRelatedWork W4244071458 @default.
- W3048609091 hasRelatedWork W4292755610 @default.
- W3048609091 hasRelatedWork W4387351442 @default.
- W3048609091 hasVolume "90" @default.
- W3048609091 isParatext "false" @default.
- W3048609091 isRetracted "false" @default.
- W3048609091 magId "3048609091" @default.
- W3048609091 workType "article" @default.